Sorafenib targets dysregulated Rho kinase expression and portal hypertension in rats with secondary biliary cirrhosis von Hennenberg, M, Trebicka, J, Stark, C, Kohistani, AZ, Heller, J, Sauerbruch, T

Volltext

Vascular hyporesponsiveness to angiotensin II in rats with CCl4-induced liver cirrhosis von Hennenberg, M., Trebicka, J., Kohistani, A. Z., Heller, J., Sauerbruch, T.

Volltext

Vascular hyporesponsiveness to angiotensin II in rats with CCl 4 ‐induced liver cirrhosis von Hennenberg, M., Trebicka, J., Kohistani, A. Z., Heller, J., Sauerbruch, T.

Volltext

Vascular hyporesponsiveness to angiotensin II in rats with CCl(4)-induced liver cirrhosis von Hennenberg, M, Trebicka, J, Kohistani, A Z, Heller, J, Sauerbruch, T

Volltext

750 ALTERATIONS IN ANGIOTENSIN-II TYPE1 RECEPTOR- MEDIATED REGULATION OF GENE EXPRESSION IN HYPOCONTRACTILE VESSELS OF RATS WITH SECONDARY BILIARY CIRRHOSIS von Hennenberg, M, Trebicka, J, Kohistani, Z, Heller, J, Sauerbruch, T

Volltext

45 SORAFENIB IN CIRRHOTIC RATS: HEPATIC EFFECTS ASSOCIATED WITH THE BENEFICAL REDUCTION OF VASCULAR RESISTANCE AND PORTAL HYPERTENSION von Hennenberg, M, Trebicka, J, Kohistani, Z, Stark, C, Heller, J, Sauerbruch, T

Volltext